Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2005-000929-31-IT
EUCTR2005-000929-31-IT
Active, not recruiting
Not Applicable

Surgery plus intraperitoneal hyperthermic chemoterapy in platinum-resistant patients with ovarian cancer reccurrence. A Phase II study.

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 sitesMarch 22, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsADRIBLASTINA INIET FL50MG/25ML

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 22, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Eligibility Criteria

Inclusion Criteria

  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Surgery plus intraperitoneal Hypertermic chemotherapy in platinum-sensitive patients with ovarian cancer recurrence after 12 months. Phase II studyRecurrent ovarian cancerMedDRA version: 6.1Level: PTClassification code 10033128
EUCTR2005-000927-41-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Active, not recruiting
Not Applicable
ovarian cancer treatment with intraabdominal chemotherapy (paclitaxel)
EUCTR2011-006319-69-ESPedro Villarejo Campos(Hospital Universitario Ciudad Real)
Active, not recruiting
Not Applicable
Hyperthermic intra-peritoneal chemotherapy (HIPEC) in Ovarian cancer recurrence: Randomized trial on Survival Evaluation.
EUCTR2012-002872-15-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Active, not recruiting
Not Applicable
Intraperitoneal hyperterm chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal origiAdjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosisthe COLOPEC randomized multicenter trialTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2014-002794-11-NLAcademic Medical Center176
Completed
Phase 3
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicenter trial.metastases of peritoneumperitoneal carcinomatosis100179901002747610017998
NL-OMON47140Academisch Medisch Centrum185